This is a discussion on Pain Patch (transdermal) for Chronic Low Back Pain--- EladurŪ (TransdurŪ-Bupivacaine) in Phase II Clinical Trial within the Education, Research and Spine Publications forums, part of the General Spine Discussion Forums category; DURECT Corporation (Nasdaq: DRRX) announced top-line results from a Phase II clinical trial in chronic low back pain for ELADURŪ ...
Pain Patch (transdermal) for Chronic Low Back Pain--- EladurŪ (TransdurŪ-Bupivacaine) in Phase II Clinical Trial DURECT Corporation (Nasdaq: DRRX) announced top-line results from a Phase II clinical trial in chronic low back pain for ELADURŪ (TRANSDURŪ-Bupivacaine), DURECT's proprietary investigational transdermal bupivacaine pain patch. This study was conducted by DURECT's collaborator, King Pharmaceuticals, which is now owned by Pfizer (NYSE: PFE).....
DURECT Announces ELADURŪ (TRANSDURŪ-Bupivacaine) Phase II Study Results In Chronic Low Back Pain (click here for the full article at Medical News Today)
Justin Averna
Founder & President, Spine Patient Society
www.SpinePatientSociety.org
A 501(c)(3) Tax-Exempt Nonprofit & Charitable Organization
I'm here to help.
- 1994: Football Injury, Severe Hyperextension
- 1997: Snow Skiing Injury
- 3/7/1997: Laminotomy L4/L5
- 1999 & 2003: Motor Vehicle Accidents (not at fault both times) --> Grade V Annular Tears L4/L5 & L5/L6
- 11/15/2003: 2-Level ProDiscŪ L4/L5 & L5/L6*, *lumbosacral transitional vertebra --> Dr. Rudolf Bertagnoli
- 4/2008: 4.5 years pain-free before "new" leg pain
- 5/14/2009: Dynamic Stabilization System L4/L5, Dr. Rudolf Bertagnoli
Questions? Suggestions? Need help with registering, creating a signature, etc.?
justin (at) spinepatientsociety.org
Disclosure: I have no financial relationships with any surgeons, spine clinics, device manufacturers, pharmaceutical companies, hospitals, etc. -- the SPS Board of Directors serve without compensation.
Posting Permissions
LinkBack URL
About LinkBacks
Reply With Quote
Bookmarks